Halloween graveyard
Biotech

The 2026 Biotech Graveyard

Join us for our annual ritual as we remember the biotechs lost this year to a tough funding environment or disappointing clinical trial readouts.
Podcast
Graphic for the Podnosis podcast by Fierce featuring a stylized heart at the center surrounded by colorful sound wave visual

When drug development gets personal

Oct 30, 2026 9:28am
Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o

Lilly International's Patrik Jonsson to retire—Chutes & Ladders

Oct 30, 2026 8:30am
A concept image to illustrate mental health medications Models of a pink brain and two white pills which are about the size

Jazz's Actio buyout gives rise to Setara with $90M series A

Oct 30, 2026 6:30am
AZ

AstraZeneca cuts early-phase prostate cancer pipeline

Oct 30, 2026 5:03am
IPO initial public offering markets raise financing

Bambusa shoots past IPO targets as Aspen trims offering

Oct 30, 2026 4:01am
More News

Sanofi mulling ‘moonshot’ M&A targets to survive Dupixent cliff

Oct 30, 2026 3:27am

Molecular Partners plots 44% staff cutback in radiotherapy pivot

Oct 30, 2026 3:18am

Lilly scraps ph. 2 Alzheimer's program after drug falls short

Oct 29, 2026 2:09pm
Fierce Pharma

For Merck, 2027 is ‘another year of investment’

Oct 29, 2026 11:23am